Abstract

To combat opioid use disorder (OUD), more than 2.2 million patients are reported to be using buprenorphine-naloxone for opioid maintenance therapy. Buprenorphine-naloxone is a semi-synthetic mu receptor agonist-antagonist with potent kappa/delta receptor antagonist effects. Due to buprenorphine's receptor pharmacology, there is a lack of unified guidelines for managing perioperative pain for surgical patients using buprenorphine-naloxone.

Author Details

Surafel Kirubel, BSN and David Fort, DNP, CRNA

Sigma Membership

Non-member

Lead Author Affiliation

Samford University, Birmingham, Alabama, USA

Type

DNP Capstone Project

Format Type

Text-based Document

Study Design/Type

Case Study/Series

Research Approach

Translational Research/Evidence-based Practice

Keywords:

Buprenorphine-Naloxone, Suboxone, Opioid Use Disorder, Pain Management

Advisor

Fort, David

Degree

Doctoral-Other

Degree Grantor

Samford University

Degree Year

2023

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

None: Degree-based Submission

Acquisition

Self-submission

Date of Issue

2023-02-01

Full Text of Presentation

wf_yes

Download

Additional Files

download (115 kB)

Share

COinS